| Mrs Amy Kleinrichert Hurt, MS CCC-SLP | |
|
19977 N.e. Marie Ave., Blountstown, FL 32424 | |
| (850) 674-3885 | |
| Not Available |
| Full Name | Mrs Amy Kleinrichert Hurt |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 19977 N.e. Marie Ave., Blountstown, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164756359 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SA10034 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Amy Kleinrichert Hurt, MS CCC-SLP 19977 Ne Marie Ave, Blountstown, FL 32424 Ph: (850) 674-3885 | Mrs Amy Kleinrichert Hurt, MS CCC-SLP 19977 N.e. Marie Ave., Blountstown, FL 32424 Ph: (850) 674-3885 |
News Archive
A large body of evidence shows that spinal circuits are significantly affected by training, and that intrinsic circuits that drive locomotor tasks are located in lumbosacral spinal segments in rats with complete spinal cord transection.
Many orthopedic surgeons are debating whether Warsaw, Ind.-based Zimmer Holdings' knee implant Gender Solutions, which is designed specifically for women, is better for women than the standard artificial knee, Reuters reports.
A new UCLA study shows that changes in certain brain receptors can affect seizures and anxiety during the menstrual cycle-findings that could lead to novel therapies for premenstrual dysphoric disorder (PMDD, formerly known as PMS) and other central nervous system symptoms associated with the menstrual cycle.
Inhaled anesthetics commonly used in surgery are more likely to cause the aggregation of Alzheimer's disease-related plaques in the brain than intravenous anesthetics say University of Pittsburgh School of Medicine researchers in a journal article published in Biochemistry.
Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a Phase I clinical trial of AGS-16M8F an antibody-drug conjugate (ADC) that is being developed for the treatment of metastatic renal cancer. An ADC uses the specific binding properties of an antibody to target a toxin in tumor cells, resulting in selective tumor cell killing.
› Verified 5 days ago
Madelyn Shiplov Price, MCD/CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 17352 Main St N, Blountstown, FL 32424 Phone: 850-674-4300 Fax: 850-674-4305 | |
Marie Castaneda, MS, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 16690 Sw Chipola Rd, Blountstown, FL 32424 Phone: 850-674-4311 |